Alterity Therapeutics Cash Flow Statement Analysis

Operating, investing, and financing activities in millions AUD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Alterity Therapeutics Limited (ATHE) - Annual data in millions AUD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2018
Period EndingDec 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2018
Operating Activities
Net Income-12.15-19.12-13.81-12.85-15.31-8.27
Depreciation & Amortization0.140.150.100.050.080.02
Stock Based Compensation0.980.880.971.511.880.00
Change in Working Capital-0.615.75-6.391.76-4.410.96
Change in Accounts Receivable0.104.62-3.94-0.45-4.220.00
Change in Accounts Payable0.001.10-1.562.600.430.00
Change in Other Working Capital-0.720.02-0.890.00-0.620.00
Other Operating Activities0.19-0.26-0.920.000.430.76
Net Cash from Operating Activities-11.45-12.61-20.04-12.34-17.33-6.25
Investing Activities
Capital Expenditures0.00-0.01-0.01-0.09-0.01-0.06
Purchases of Investments-7.500.000.000.000.000.00
Other Investing Activities0.000.00-0.030.000.000.04
Net Cash from Investing Activities-7.50-0.01-0.04-0.09-0.01-0.02
Financing Activities
Debt Repayment-0.13-0.01-0.06-0.030.000.00
Common Stock Issued42.5710.140.3217.1839.240.00
Other Financing Activities-2.77-0.92-0.13-0.84-2.49-0.11
Net Cash from Financing Activities39.679.220.1216.3036.69-0.11
Summary
Effect of Forex Changes on Cash-0.200.260.912.810.00-0.28
Net Change in Cash20.52-3.13-19.953.8818.92-6.37
Cash at Beginning of Period12.6415.7734.8128.120.0021.88
Cash at End of Period33.1612.6415.7734.810.0015.24
Free Cash Flow-11.45-12.61-20.04-12.43-17.34-6.31
Supplemental Disclosures
Interest Paid0.000.010.000.000.000.00
Income Taxes Paid-5.56-8.530.10-4.080.000.00